***Additional Mega DD***Wallstreet Analysts Price predictions: $12.50
WallStreet Journal Price Targets: High $18.00 Medium: $12.50 Low $8.00
Brokerage Firm Ratings: 1 Buy rating, 2 Outperform 0 Sell and 0 Hold ratings
Valence Helix and affiliates recently acquired an 10.99% stake last month
CEO bought 571,428 shares @ $1.75
CFO bought 571,428 shares @ $1.75
COO bought 571,428 shares @ $1.75
Partnerships w/ Merck, Roche, Pfizer, Eli Lilly (owns 18% of LPTX)
72% tumor reduction
$LPTX